| Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation E Zamagni, F Patriarca, C Nanni, B Zannetti, E Englaro, A Pezzi, ... Blood 118 (23), 5989-5995, 2011 | 302 | 2011 |
| Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for … JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ... Journal of Nuclear Medicine 56 (8), 1185-1190, 2015 | 279 | 2015 |
| Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE I Virgolini, V Ambrosini, JB Bomanji, RP Baum, S Fanti, M Gabriel, ... European journal of nuclear medicine and molecular imaging 37 (10), 2004-2010, 2010 | 265 | 2010 |
| Detection and localization of prostate cancer: correlation of 11C-choline PET/CT with histopathologic step-section analysis M Farsad, R Schiavina, P Castellucci, C Nanni, B Corti, G Martorana, ... Journal of Nuclear Medicine 46 (10), 1642-1649, 2005 | 265 | 2005 |
| 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with … R Schiavina, V Scattoni, P Castellucci, M Picchio, B Corti, A Briganti, ... European urology 54 (2), 392-401, 2008 | 249 | 2008 |
| A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the … E Zamagni, C Nanni, F Patriarca, E Englaro, P Castellucci, O Geatti, ... Haematologica 92 (1), 50-55, 2007 | 241 | 2007 |
| Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy P Castellucci, C Fuccio, C Nanni, I Santi, A Rizzello, F Lodi, ... Journal of Nuclear Medicine 50 (9), 1394-1400, 2009 | 235 | 2009 |
| Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours V Ambrosini, P Tomassetti, P Castellucci, D Campana, G Montini, ... European journal of nuclear medicine and molecular imaging 35 (8), 1431-1438, 2008 | 225 | 2008 |
| 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors V Ambrosini, D Campana, L Bodei, C Nanni, P Castellucci, V Allegri, ... Journal of Nuclear Medicine 51 (5), 669-673, 2010 | 221 | 2010 |
| Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT V Prasad, V Ambrosini, M Hommann, D Hoersch, S Fanti, RP Baum European journal of nuclear medicine and molecular imaging 37 (1), 67, 2010 | 216 | 2010 |
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 S Gillessen, A Omlin, G Attard, JS de Bono, E Efstathiou, K Fizazi, ... Annals of Oncology 26 (8), 1589-1604, 2015 | 214 | 2015 |
| The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of … M Picchio, A Briganti, S Fanti, A Heidenreich, BJ Krause, C Messa, ... European urology 59 (1), 51-60, 2011 | 203 | 2011 |
| Prostate Cancer: Sextant Localization with MR Imaging, MR Spectroscopy, and 11C-Choline PET/CT1 C Testa, R Schiavina, R Lodi, E Salizzoni, B Corti, M Farsad, ... Radiology 244 (3), 797-806, 2007 | 202 | 2007 |
| Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy C Capirci, L Rampin, PA Erba, F Galeotti, G Crepaldi, E Banti, M Gava, ... European journal of nuclear medicine and molecular imaging 34 (10), 1583-1593, 2007 | 195 | 2007 |
| 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ... European journal of nuclear medicine and molecular imaging 42 (8), 1284-1294, 2015 | 178 | 2015 |
| Radiopeptide imaging and therapy in Europe V Ambrosini, M Fani, S Fanti, F Forrer, HR Maecke Journal of Nuclear Medicine 52 (2), 42S, 2011 | 178 | 2011 |
| Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours A Chiti, S Fanti, G Savelli, A Romeo, B Bellanova, M Rodari, ... European journal of nuclear medicine 25 (10), 1396-1403, 1998 | 177 | 1998 |
| Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis C Rapezzi, CC Quarta, PL Guidalotti, C Pettinato, S Fanti, O Leone, ... JACC: Cardiovascular Imaging 4 (6), 659-670, 2011 | 159 | 2011 |
| Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? P Castellucci, C Fuccio, D Rubello, R Schiavina, I Santi, C Nanni, ... European journal of nuclear medicine and molecular imaging 38 (1), 55-63, 2011 | 159 | 2011 |
| Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and … P Castellucci, AM Perrone, M Picchio, T Ghi, M Farsad, C Nanni, C Messa, ... Nuclear medicine communications 28 (8), 589-595, 2007 | 158 | 2007 |
Pier Luigi ZinzaniUniversità di BolognaVerified email at unibo.it